Localization of N-myc downstream-regulated gene 1 in gastric cancer tissue

Digestive and Liver Disease

Volumn 41, Issue 2, 2009, Pages 96-103

  Inagaki, Y ^a   Tang, W ^a   Xu, H L ^a   Guo, Q ^a   Mafune, K ^b   Konishi, T ^c   Nakata, M ^d   Sugawara, Y ^a   Kokudo, N ^a  

^a University of Tokyo   (Japan)

^b International University of Health and Welfare Mita Hospital   (Japan)

^c Kanto Teishin Hospital   (Japan)

^d TOKAI UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Metastasis suppressor; NDRG1; p53

Indexed keywords

BIOCHEMICAL MARKER; NDRG1 PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN LOCALIZATION; STOMACH CANCER; SURVIVAL RATE; TISSUE DISTRIBUTION;

ADULT; AGED; AGED, 80 AND OVER; CELL CYCLE PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 58149143253     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2008.04.003     Document Type: Article

References (40)

1. Kokame K., Kato H., and Miyata T. Homocystein-respondent genes in vascular endothelial cells identified by differential display analysis. J Biol Chem 271 (1996) 29659-29665
2. van Belzen N., Dinjens W.N., Diesveld M.P., Groen N.A., van der Made A.C., Nozawa Y., et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77 (1997) 85-92
3. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., and Bosman F.T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118 (2002) 399-408
4. Salnikow K., Blagosklonny M., Ryan H., Johnson R., and Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60 (2000) 38-41
5. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Commes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450 (1999) 364-373
6. Ulrix W., Swinnen J.V., Heyns W., and Verhoeven G. The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett 455 (1999) 23-26
7. Nimmrich I., Erdmann S., Melchers U., Finke U., Hentsch S., Moyer M.P., et al. Seven genes that are differentially transcribed in colorectal tumor cell lines. Cancer Lett 160 (2000) 37-43
8. Segawa T., Nau M.E., Xu L.L., Chilukuri R.N., Makarem M., Zhang W., et al. Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells. Oncogene 21 (2002) 8749-8758
9. Bandyopadhyay S., Pai S.K., Gross S.C., Hirota S., Hosobe S., Miura K., et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63 (2003) 1731-1736
10. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., and Pardee A.B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60 (2000) 749-755
11. Rutherfold M.N., Bayly G.R.L., Matthews B.P., Okuda T., Dinjrns W.M.N., Kondoh H., et al. The leukemogenic transcription factor E2a-Pbx induces expression of the putative N-myc and p53 target gene NDRG1 in Ba/F3 cells. Leukemia 15 (2001) 362-370
12. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., and Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damaging. Cancer Res 58 (1998) 4439-4444
13. Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V., Jackson R.S., et al. NDRG1 is necessary for p53-dependent apoptosis. J Biol Chem 279 (2004) 48930-48940
14. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma-2nd English edition references. Gastric Cancer 1998;1:10-24.
15. Sobin L.H., and Wittekind C. TNM classification of malignant tumors. 5th ed. (1997), Wiley-Liss, New York
16. Finlay C.A., Hinds P.W., Tan T.-H., Eliyahu D., Oren M., and Levine A.J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8 (1988) 531-539
17. Ireland A., Clark G., and Demeester T. Barrett's esophagus: the significance of p53 in clinical practice. Ann Surg 225 (1997) 17-30
18. Baas I.O., Mulder J.W., Offerhaus G.J., Vogelstein B., and Hamilton S.R. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172 (1994) 5-12
19. Angst E., Sibold S., Tiffon C., Weimann R., Gloor B., Candinas D., et al. Cellular differentiation determines the expression of the hypoxia-inducible protein NDRG1 in pancreatic cancer. Br J Cancer 95 (2006) 307-313
20. Okuda T., and Kondoh H. Identification of new genes ndr2 and ndr3 which are related to Ndr1/RTP/Drg1 but show distinct tissue specificity and response to N-myc. Biochem Biophys Res Commun 266 (1999) 208-215
21. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Coomes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim Biophys Acta 1450 (1999) 364-373
22. Qu X., Zhai Y., Wei H., Zhang C., Xing G., Yu Y., et al. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229 (2002) 35-44
23. Yoshizumi T., Ohta T., Ninomiya I., Terada I., Fushida S., Fujimura T., et al. Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. Int J Oncol 25 (2004) 631-639
24. Ellen T., Ke Q., Zhang P., and Costa M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis (2007)
25. Cangul H., Salnikow K., Yee H., Zagzag D., Commes T., and Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ Health Perspect 5 (2002) 783-788
26. Cangul H. Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers. BMC Genet 5 (2004) 27
27. Sibold S., Roh V., Keogh A., Studer P., Tiffon C., Angst E., et al. Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma. FEBS Lett 581 (2007) 989-994
28. Hockel M., and Vaupel P. Tumor hypoxia definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93 (2001) 266-276
29. Takahashi R., Tanaka S., Hiyama T., Ito M., Kitadai Y., Sumii M., et al. Hypoxia-inducible factor-1alpha expression and angiogenesis in gastrointestinal stromal tumor of the stomach. Oncol Rep 10 (2003) 797-802
30. Maruyama Y., Ono M., Kawahara A., Yokoyama T., Basaki Y., Kage M., et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66 (2006) 6233-6242
31. Cho J.H., and Kim W.H. Altered topographic expression of p21WAF1/CIP1/SDI1, bcl2 and p53 during gastric carcinogenesis. Pathol Res Pract 194 (1998) 309-317
32. Marx J. How p53 suppresses cell growth. Science 262 (1993) 1644-1645
33. Vogelstein B., and Kinzler K.W. p53 function and dysfunction. Cell 70 (1992) 523-526
34. Feng C.W., Wang L.D., Jiao L.H., Liu B., Zheng S., and Xie X.J. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. BMC Cancer 2 (2002) 8
35. Rajnakova A., Moochhala S., Goh P.M., and Ngoi S. Expression of nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Lett 172 (2001) 177-185
36. Xu Y. Induction of genetic instability by gain-of-function p53 cancer mutants. Oncogene (2008) 1-7
37. Ho J.S., Ma W., Mao D.Y., and Benchimol S. p53-dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol Cell Biol 25 (2005) 7423-7431
38. Forones N.M., Carvalho A.P., Giannotti-Filho O., Lourenco L.G., and Oshima C.T. Cell proliferation and apoptosis in gastric cancer and intestinal metaplasia. Arq Gastroenterol 42 (2005) 30-34
39. Xu A.G., Li S.G., Liu J.H., and Gan A.H. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. World J Gastroenterol 7 (2001) 403-406
40. Xu B., Lin L., and Rote N.S. Identification of a stress-induced protein during human trophoblast differentiation by differential display analysis. Biol Reprod 61 (1999) 681-686